CollPlant Biotechnologies (CLGN) Non-cash Items (2018 - 2025)
CollPlant Biotechnologies (CLGN) reported Non-cash Items of $6876.0 for Q4 2025, down 97.81% on a YoY basis from $314000.0 in Q4 2024, and down 97.81% quarter-over-quarter from $314000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Non-cash Items (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Non-cash Items for 7 years, with the latest figure at $6876.0 in Q4 2025.
- For the quarter ending Q4 2025, Non-cash Items fell 97.81% year-over-year to $6876.0; the trailing twelve-month figure through Dec 2025 stood at $6876.0 (down 97.81% YoY), and the FY2025 full-year result was $6876.0, down 97.81% from the prior year.
- Non-cash Items for Q4 2025 stood at $6876.0, down from $314000.0 in the prior quarter.
- The five-year high for Non-cash Items was $8.2 million in Q2 2021, with the low at $6876.0 in Q4 2025.
- Historically, Non-cash Items has averaged $2.4 million across 4 years, with a median of $732507.5 in 2023.
- Annual changes were most pronounced in 2021 — Non-cash Items surged 425.76% — and 2025, when it tumbled 97.81%.
- CollPlant Biotechnologies' Non-cash Items stood at $8.2 million in 2021, then plunged by 86.0% to $1.2 million in 2023, then sank by 72.72% to $314000.0 in 2024, then plunged by 97.81% to $6876.0 in 2025.
- The last three Non-cash Items figures came in at $6876.0 (Q4 2025), $314000.0 (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,876.00 |
| Dec 31, 2025 | 6,876.00 |
| Dec 31, 2024 | 314,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Dec 31, 2023 | 1.15 Mn |
| Dec 31, 2023 | 1.15 Mn |
| Jun 30, 2021 | 8.22 Mn |
| Jun 30, 2021 | 8.22 Mn |
| Jun 30, 2020 | -2.52 Mn |
| Jun 30, 2020 | -2.52 Mn |
| Jun 30, 2019 | -2.02 Mn |
| Jun 30, 2019 | -2.02 Mn |
| Jun 30, 2018 | -2.17 Mn |
| Jun 30, 2018 | -2.17 Mn |